Natural Killer Cell Therapy-Global Market Status and Trend Report 2016-2026
Report Summary
Natural Killer Cell Therapy-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Natural Killer Cell Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Natural Killer Cell Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Natural Killer Cell Therapy worldwide, with company and product introduction, position in the Natural Killer Cell Therapy market
Market status and development trend of Natural Killer Cell Therapy by types and applications
Cost and profit status of Natural Killer Cell Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Natural Killer Cell Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapy industry.
The report segments the global Natural Killer Cell Therapy market as:
Global Natural Killer Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Natural Killer Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
NK Cell Therapies
NK Cell Directed Antibodies
Global Natural Killer Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Natural Killer Cell Therapy-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Natural Killer Cell Therapy industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Natural Killer Cell Therapy 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Natural Killer Cell Therapy worldwide, with company and product introduction, position in the Natural Killer Cell Therapy market
Market status and development trend of Natural Killer Cell Therapy by types and applications
Cost and profit status of Natural Killer Cell Therapy, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Natural Killer Cell Therapy market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapy industry.
The report segments the global Natural Killer Cell Therapy market as:
Global Natural Killer Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Natural Killer Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
NK Cell Therapies
NK Cell Directed Antibodies
Global Natural Killer Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Cancer
Gastrointestinal Diseases
Others
Global Natural Killer Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Natural Killer Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF NATURAL KILLER CELL THERAPY
1.1 Definition of Natural Killer Cell Therapy in This Report
1.2 Commercial Types of Natural Killer Cell Therapy
1.2.1 NK Cell Therapies
1.2.2 NK Cell Directed Antibodies
1.3 Downstream Application of Natural Killer Cell Therapy
1.3.1 Cancer
1.3.2 Gastrointestinal Diseases
1.3.3 Others
1.4 Development History of Natural Killer Cell Therapy
1.5 Market Status and Trend of Natural Killer Cell Therapy 2016-2026
1.5.1 Global Natural Killer Cell Therapy Market Status and Trend 2016-2026
1.5.2 Regional Natural Killer Cell Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natural Killer Cell Therapy 2016-2021
2.2 Production Market of Natural Killer Cell Therapy by Regions
2.2.1 Production Volume of Natural Killer Cell Therapy by Regions
2.2.2 Production Value of Natural Killer Cell Therapy by Regions
2.3 Demand Market of Natural Killer Cell Therapy by Regions
2.4 Production and Demand Status of Natural Killer Cell Therapy by Regions
2.4.1 Production and Demand Status of Natural Killer Cell Therapy by Regions 2016-2021
2.4.2 Import and Export Status of Natural Killer Cell Therapy by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Natural Killer Cell Therapy by Types
3.2 Production Value of Natural Killer Cell Therapy by Types
3.3 Market Forecast of Natural Killer Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Natural Killer Cell Therapy by Downstream Industry
4.2 Market Forecast of Natural Killer Cell Therapy by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NATURAL KILLER CELL THERAPY
5.1 Global Economy Situation and Trend Overview
5.2 Natural Killer Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 NATURAL KILLER CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Natural Killer Cell Therapy by Major Manufacturers
6.2 Production Value of Natural Killer Cell Therapy by Major Manufacturers
6.3 Basic Information of Natural Killer Cell Therapy by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Natural Killer Cell Therapy Major Manufacturer
6.3.2 Employees and Revenue Level of Natural Killer Cell Therapy Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NATURAL KILLER CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Nektar Therapeutics
7.1.1 Company profile
7.1.2 Representative Natural Killer Cell Therapy Product
7.1.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nektar Therapeutics
7.2 Innate Pharma SA
7.2.1 Company profile
7.2.2 Representative Natural Killer Cell Therapy Product
7.2.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Innate Pharma SA
7.3 Affimed
7.3.1 Company profile
7.3.2 Representative Natural Killer Cell Therapy Product
7.3.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Affimed
7.4 Chipscreen Biosciences
7.4.1 Company profile
7.4.2 Representative Natural Killer Cell Therapy Product
7.4.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences
7.5 Glycostem Therapeutics
7.5.1 Company profile
7.5.2 Representative Natural Killer Cell Therapy Product
7.5.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Glycostem Therapeutics
7.6 Fate Therapeutics
7.6.1 Company profile
7.6.2 Representative Natural Killer Cell Therapy Product
7.6.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Fate Therapeutics
7.7 Dragonfly Therapeutics
7.7.1 Company profile
7.7.2 Representative Natural Killer Cell Therapy Product
7.7.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Dragonfly Therapeutics
7.8 Kiadis Pharma
7.8.1 Company profile
7.8.2 Representative Natural Killer Cell Therapy Product
7.8.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Kiadis Pharma
7.9 Nkarta Therapeutics
7.9.1 Company profile
7.9.2 Representative Natural Killer Cell Therapy Product
7.9.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nkarta Therapeutics
7.10 NantKwest
7.10.1 Company profile
7.10.2 Representative Natural Killer Cell Therapy Product
7.10.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of NantKwest
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATURAL KILLER CELL THERAPY
8.1 Industry Chain of Natural Killer Cell Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NATURAL KILLER CELL THERAPY
9.1 Cost Structure Analysis of Natural Killer Cell Therapy
9.2 Raw Materials Cost Analysis of Natural Killer Cell Therapy
9.3 Labor Cost Analysis of Natural Killer Cell Therapy
9.4 Manufacturing Expenses Analysis of Natural Killer Cell Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF NATURAL KILLER CELL THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Natural Killer Cell Therapy in This Report
1.2 Commercial Types of Natural Killer Cell Therapy
1.2.1 NK Cell Therapies
1.2.2 NK Cell Directed Antibodies
1.3 Downstream Application of Natural Killer Cell Therapy
1.3.1 Cancer
1.3.2 Gastrointestinal Diseases
1.3.3 Others
1.4 Development History of Natural Killer Cell Therapy
1.5 Market Status and Trend of Natural Killer Cell Therapy 2016-2026
1.5.1 Global Natural Killer Cell Therapy Market Status and Trend 2016-2026
1.5.2 Regional Natural Killer Cell Therapy Market Status and Trend 2016-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Natural Killer Cell Therapy 2016-2021
2.2 Production Market of Natural Killer Cell Therapy by Regions
2.2.1 Production Volume of Natural Killer Cell Therapy by Regions
2.2.2 Production Value of Natural Killer Cell Therapy by Regions
2.3 Demand Market of Natural Killer Cell Therapy by Regions
2.4 Production and Demand Status of Natural Killer Cell Therapy by Regions
2.4.1 Production and Demand Status of Natural Killer Cell Therapy by Regions 2016-2021
2.4.2 Import and Export Status of Natural Killer Cell Therapy by Regions 2016-2021
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Natural Killer Cell Therapy by Types
3.2 Production Value of Natural Killer Cell Therapy by Types
3.3 Market Forecast of Natural Killer Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Natural Killer Cell Therapy by Downstream Industry
4.2 Market Forecast of Natural Killer Cell Therapy by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF NATURAL KILLER CELL THERAPY
5.1 Global Economy Situation and Trend Overview
5.2 Natural Killer Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 6 NATURAL KILLER CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Natural Killer Cell Therapy by Major Manufacturers
6.2 Production Value of Natural Killer Cell Therapy by Major Manufacturers
6.3 Basic Information of Natural Killer Cell Therapy by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Natural Killer Cell Therapy Major Manufacturer
6.3.2 Employees and Revenue Level of Natural Killer Cell Therapy Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 NATURAL KILLER CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Nektar Therapeutics
7.1.1 Company profile
7.1.2 Representative Natural Killer Cell Therapy Product
7.1.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nektar Therapeutics
7.2 Innate Pharma SA
7.2.1 Company profile
7.2.2 Representative Natural Killer Cell Therapy Product
7.2.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Innate Pharma SA
7.3 Affimed
7.3.1 Company profile
7.3.2 Representative Natural Killer Cell Therapy Product
7.3.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Affimed
7.4 Chipscreen Biosciences
7.4.1 Company profile
7.4.2 Representative Natural Killer Cell Therapy Product
7.4.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Chipscreen Biosciences
7.5 Glycostem Therapeutics
7.5.1 Company profile
7.5.2 Representative Natural Killer Cell Therapy Product
7.5.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Glycostem Therapeutics
7.6 Fate Therapeutics
7.6.1 Company profile
7.6.2 Representative Natural Killer Cell Therapy Product
7.6.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Fate Therapeutics
7.7 Dragonfly Therapeutics
7.7.1 Company profile
7.7.2 Representative Natural Killer Cell Therapy Product
7.7.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Dragonfly Therapeutics
7.8 Kiadis Pharma
7.8.1 Company profile
7.8.2 Representative Natural Killer Cell Therapy Product
7.8.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Kiadis Pharma
7.9 Nkarta Therapeutics
7.9.1 Company profile
7.9.2 Representative Natural Killer Cell Therapy Product
7.9.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of Nkarta Therapeutics
7.10 NantKwest
7.10.1 Company profile
7.10.2 Representative Natural Killer Cell Therapy Product
7.10.3 Natural Killer Cell Therapy Sales, Revenue, Price and Gross Margin of NantKwest
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF NATURAL KILLER CELL THERAPY
8.1 Industry Chain of Natural Killer Cell Therapy
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF NATURAL KILLER CELL THERAPY
9.1 Cost Structure Analysis of Natural Killer Cell Therapy
9.2 Raw Materials Cost Analysis of Natural Killer Cell Therapy
9.3 Labor Cost Analysis of Natural Killer Cell Therapy
9.4 Manufacturing Expenses Analysis of Natural Killer Cell Therapy
CHAPTER 10 MARKETING STATUS ANALYSIS OF NATURAL KILLER CELL THERAPY
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
